Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet van Riel

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Arthritis Research & Therapy|April 25, 2020
Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age modelsGrunde Wibetoe, Joseph Sexton, Eirik Ikdahl, et al.
Annals of the Rheumatic Diseases|August 19, 2021
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia M T Roodenrijs, Paco M J Welsing, et al.
Annals of the Rheumatic Diseases|May 7, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen, Robert Landewé, Ferdinand C Breedveld, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
RMD Open|July 10, 2021
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditAnne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
International Journal of Epidemiology|August 20, 2015
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritisS Hong Lee, Enda M Byrne, Christina M Hultman, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Arthritis Research & Therapy|April 25, 2020
Prediction of cardiovascular events in rheumatoid arthritis using risk age calculations: evaluation of concordance across risk age modelsGrunde Wibetoe, Joseph Sexton, Eirik Ikdahl, et al.
Annals of the Rheumatic Diseases|August 19, 2021
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Nadia M T Roodenrijs, Paco M J Welsing, et al.
Annals of the Rheumatic Diseases|May 7, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsJosef S Smolen, Robert Landewé, Ferdinand C Breedveld, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
RMD Open|July 10, 2021
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditAnne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
Annals of the Rheumatic Diseases|March 8, 2017
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateJosef S Smolen, Robert Landewé, Johannes Bijlsma, et al.
International Journal of Epidemiology|August 20, 2015
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritisS Hong Lee, Enda M Byrne, Christina M Hultman, et al.
Pageof 6